Oncology Overview: Investigational Imlunestrant for Breast Cancer, Endometrial Cancer
June 22nd 2022Imlunestrant is currently under investigation as monotherapy or in combination with other anticancer therapies for patients with estrogen receptor-positive, locally advanced or metastatic breast cancer and endometrial cancer.
Read More